Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients

Abstract The assessment of ctDNA has emerged as a minimally invasive avenue for molecular diagnosis and real-time tracking of tumor progression in NSCLC. However, the evaluation of ctDNA by amplicon-based NGS has been not endorsed by all the healthcare systems and remains to be fully integrated into...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Valerio Gristina, Tancredi Didier Bazan Russo, Nadia Barraco, Andrea Gottardo, Francesco Pepe, Gianluca Russo, Fabio Fulfaro, Lorena Incorvaia, Giuseppe Badalamenti, Giancarlo Troncone, Umberto Malapelle, Antonio Russo, Viviana Bazan, Antonio Galvano
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-09-01
Subjects:	NSCLC Liquid biopsy CtDNA NGS Monitoring
Online Access:	https://doi.org/10.1038/s41598-024-73046-y